Noncoding RNAs as Players, Biomarkers and Targets in Diabetes
A special issue of Diabetology (ISSN 2673-4540).
Deadline for manuscript submissions: closed (31 March 2022) | Viewed by 611
Special Issue Editor
2. Lecturer at Tel Hai Academic College, Qiryat Shemona, Israel
3. Visiting Researcher at the Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark
Interests: diabetes; noncoding RNAs; microRNAs; transcriptomics; molecular mechanisms of metabolic diseases and cancer; molecular links between chronic diseases; biomarkers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Noncoding RNAs (such as microRNAs, lncRNAs and circular RNAs) have a variety of functions in normal physiology, and take part in the regulatory mechanisms which are deregulated in metabolic disease. Their specific profiles in body fluids, such as plasma and serum, has led to the search for RNA-based biomarkers of disease, in particular diabetes and its co-morbidities. Additionally, the relative ease of manipulation of their function, e.g., by means of complementary oligonucleotides, has underscored their potential as therapeutic targets. In this Special Issue of Diabetology, we invite researchers to submit original research or review articles focusing on the various classes of ncRNAs as mechanistic effectors, biomarkers and/ or therapeutic targets in diabetes and/or its co-morbidities.
Dr. Ari Meerson
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diabetology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- noncoding RNAs
- lncRNA
- microRNA
- miRNA
- circular RNA
- circRNA
- tRNA fragments
- biomarkers
- co-morbidities
- antisense
- RNAi
- extracellular vesicles
- oligonucleotides
- RNA therapy
- NGS
- qRT-PCR
- regulation of gene expression
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
